Juris Pokrotnieks

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Inflammatory bowel diseases

Neurogastroenterology and motility

Digestive diseases and sciences

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

Rīga Stradiņš Universitāte Medicīnas Fakultāte

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rīga Stradiņš Universitāte Medicīnas Fakultāte Feb 20 2014

Latvia

Prof. :: Internal Diseases

Publications

Irēna Teterina, Veronika Mirzajanova, Viktorija Mokricka, Maksims Zolovs, Dins Smits, Juris Pokrotnieks
National 30-Day Readmission Trends in IBD 2014-2020-Are We Aiming for Improvement? Medicina (Kaunas, Lithuania) 60 (8) (2024)
Juris Pokrotnieks, Stanislav Sitkin
He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome. Neurogastroenterology and motility 36 (8) (2024)
Juris Pokrotnieks, Stanislav Sitkin
He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome. Neurogastroenterology and motility (2024)
Juris Pokrotnieks, Stanislav Sitkin
He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome. Neurogastroenterology and motility 36 (8) (2024)
Juris Pokrotnieks, Stanislav Sitkin
Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma. Inflammatory bowel diseases 29 (3) (2023)
Juris Pokrotnieks, Stanislav Sitkin
Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma. Inflammatory bowel diseases 29 (3) (2023)
Stanislav Sitkin, Juris Pokrotnieks
Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Juris Pokrotnieks, Stanislav Sitkin
Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma. Inflammatory bowel diseases (2022)
Stanislav Sitkin, Timur Vakhitov, Juris Pokrotnieks
Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 33 (1) (2020)
Stanislav Sitkin, Juris Pokrotnieks
Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same. Digestive diseases and sciences 66 (3) (2020)

Juris Pokrotnieks.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Juris Pokrotnieks